MP64-12 AKR1C3, AS A NOVEL TARGET OF DAB2IP SIGNALING, MAINTAINS THE PROTEIN STABILITY OF ANDROGEN RECEPTOR SPLICING VARIANT IN PROSTATE CANCER

Bin Wang,Dalin He

DOI: https://doi.org/10.1016/j.juro.2018.02.2057

IF: 7.6

2018-01-01

The Journal of Urology

Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology II1 Apr 2018MP64-12 AKR1C3, AS A NOVEL TARGET OF DAB2IP SIGNALING, MAINTAINS THE PROTEIN STABILITY OF ANDROGEN RECEPTOR SPLICING VARIANT IN PROSTATE CANCER Bin Wang, Dalin He, Jer-Tsong Hsieh, and Kaijie Wu Bin WangBin Wang More articles by this author , Dalin HeDalin He More articles by this author , Jer-Tsong HsiehJer-Tsong Hsieh More articles by this author , and Kaijie WuKaijie Wu More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2057AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Patients will inevitably relapse with castration-resistant prostate cancer (CRPC) after the failure of androgen deprivation therapy, and our previous studies have shown that the deficiency of DAB2IP, a well-known tumor suppressor, may be involved. Its loss will not only lead to the hyperactivation of androgen receptor (AR), but also increase AKR1C3 expression and de novo androgen synthesis. In this study, we will further unveil the mechanism of ARK1C3 gene expression regulated by DAB2IP, and explore its potential role in regulation of androgen receptor splicing variant (i.e., ARv7) expression in prostate cancer (PCa) cells. METHODS AKR1C3 gene regulation by DAB2IP was determined in different PCa cells (C4-2, LAPC-4 and 22RV1) with lentivirus transduction, gene expression and chromatin immunoprecipitation assays. Then a series of biochemical, molecular and cell biologic methods were employed to characterize the impacts of AKR1C3 on ARv7 in PCa cells. Also, xenograft animal model and clinical specimens were used to validate in vitro results. RESULTS The expression of AKR1C3 gene was suppressed on the transcriptional level by DAB2IP through the inhibition of AKT/mTOR/ETS-1 signaling. Functionally, AKR1C3 overexpression will increase the expression of ARv7 protein by forming a complex with ARv7 and then enhancing ARV7 protein stability through ubiquitin pathway, which could subsequently maintain the constitutive AR activation and PCa cell growth in the absence of androgen. Moreover, there was a significantly positive correlation between AKR1C3 and ARv7 expression in tissues from xenografts and human RCC specimens. CONCLUSIONS Besides the role as a critical steroidogenic enzyme in androgen synthesis, AKR1C3 upregulation triggered by upsteam signaling could also contribute to the aberrant ARv7 overexpression and CRPC development. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e855 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Bin Wang More articles by this author Dalin He More articles by this author Jer-Tsong Hsieh More articles by this author Kaijie Wu More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...